Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach
- 2 August 2017
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (10) , 1849-1858
Abstract
Multiple sclerosis (MS) is a demyelinating and neurodegenerative disease of the central nervous system (CNS), most probably autoimmune in origin, usually occurring in young adults with a female/male prevalence of approximately 3:1. Women with MS in the reproductive age may face challenging issues in reconciling the desire for parenthood with their condition, owing to the possible influence both on the ongoing or planned treatment with the possible consequences on the disease course and on the potential negative effects of treatments on foetal and pregnancy outcomes. At MS diagnosis, timely counselling should promote informed parenthood, while disease evolution should be assessed before making therapeutic decisions. Current guidelines advise the discontinuation of any treatment during pregnancy, with possible exceptions for some treatments in patients with very active disease. Relapses decline during pregnancy but are more frequent during puerperium, when MS therapy should be promptly resumed in most of the cases. First-line immunomodulatory agents, such as interferon-β (IFN-β) and glatiramer acetate (GA), significantly reduce the post-partum risk of relapse. Due to substantial evidence of safety with the use of GA during pregnancy, a recent change in European marketing authorization removed the pregnancy contraindication for GA. This paper reports a consensus of Italian experts involved in MS management, including neurologists, gynaecologists and psychologists. This consensus, based on a review of the available scientific evidence, promoted an interdisciplinary approach to the management of pregnancy in MS women.Keywords
This publication has 62 references indexed in Scilit:
- Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyBMC Neurology, 2012
- Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyBMC Neurology, 2012
- Disease-modifying drugs for multiple sclerosis in pregnancyNeurology, 2012
- Reproductive decision making after the diagnosis of multiple sclerosis (MS)Multiple Sclerosis Journal, 2012
- Committee Opinion No. 495: Vitamin D: Screening and Supplementation During PregnancyObstetrics & Gynecology, 2011
- Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosisNeurology, 2010
- Multiple sclerosisThe Lancet, 2008
- Maternal corticosteroid use and orofacial cleftsAmerican Journal of Obstetrics and Gynecology, 2007
- Fertility in patients with multiple sclerosis: current knowledge and future perspectivesNeurological Sciences, 2006
- Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide studyAnnals of Neurology, 2005